Biostage, Inc. Common Stock
BSTG
BSTG was delisted on the 5th of October, 2017.
28 hedge funds and large institutions have $5.38M invested in Biostage, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 8 closing their positions.
152% more capital invested
Capital invested by funds: $2.13M → $5.38M (+$3.25M)
7% less funds holding
Funds holding: 30 → 28 (-2)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$332K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$308K |
| 3 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$125K |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$87.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$474K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$347K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$159K |
| 4 |
SCM
Sio Capital Management
New York
|
-$99K |
| 5 |
NSEDCP
NJ State Employees Deferred Compensation Plan
Trenton,
New Jersey
|
-$42K |
BSTG Hedge Fund Activity: Q4 2015 in Review
28 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2015, worth a combined $5.38M — up 152% from $2.13M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BSTG and 6 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 7 added.
The largest buyer was Renaissance Technologies, adding an estimated $332K. The largest seller was State of New Jersey Common Pension Fund D, cutting an estimated $474K.
- 28 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2015, down from 30 in Q3 2015.
- Funds reported $5.38M of Biostage, Inc. Common Stock stock for Q4 2015, up 152% quarter-over-quarter.
- 6 funds opened new Biostage, Inc. Common Stock positions in Q4 2015 and 8 closed out, a net change of -2 holders.
- The largest Biostage, Inc. Common Stock buyer in Q4 2015 was Renaissance Technologies, an estimated $332K added.
- The largest Biostage, Inc. Common Stock seller in Q4 2015 was State of New Jersey Common Pension Fund D, an estimated $474K sold.
Based on aggregated 13F filings for Q4 2015.